Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Organoclick AB is a Swedish company specializing in the development and production of environmentally friendly chemical products and technologies. Its primary focus is on producing sustainable alternatives to traditional chemicals, aiming to minimize environmental impact. Organoclick's offerings include biobased binders for nonwoven fabrics, water-repellent treatments for textiles, and non-toxic wood preservatives. The company's innovations have significant applications across various industries, particularly in textiles, construction, and agriculture, where there is a growing demand for sustainable practices. Operating from its base in Sweden, Organoclick contributes to the push for greener solutions in chemical manufacturing, emphasizing the importance of sustainability and eco-friendliness in modern industrial processes. The company's efforts are increasingly relevant as industries worldwide pivot towards more sustainable and responsible manufacturing practices, aligning with global environmental goals.
kr 0.01
+kr 0.00 (+11.43%)
Live · 11:02 PM · Twelve Data
The business is unprofitable at the operating level (-29.23% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 16.5% YoY. Margins deteriorated 20.9pp alongside, both lines moving the wrong way.
ROIC dropped from -7.82% to -24.15%, capital efficiency is deteriorating. Negative free cash flow of -kr 19M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
kr 98M
▼ -16.5% YoY
Net Income (TTM)
-kr 36M
▼ -134.9% YoY
Op. Margin
-29.37%
▼ -20.9pp YoY
ROIC
-24.15%
▼ -16.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-kr 9M
▼ -250.0% YoY
Op. Cash Flow (TTM)
kr 6M
▼ -2625.2% YoY
Net Debt
kr 83M
Cash & Equiv.
kr 3M
3Y CAGR: -2.6%
Continue Research
Organoclick AB (ORGC.XSTO)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Organoclick AB scores 15/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Organoclick AB scores 15 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -29.4% operating margin and a -24.2% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh ORGC.XSTO's valuation and scores 15/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.